Beranda › Pendarahan › Indiana › Indianapolis
Uji klinis Pendarahan di Indianapolis, IN
5 studi untuk Pendarahan mencari peserta di lokasi sekitar Indianapolis (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Menerima pesertaFase 3
- Innovative Hematology, Inc., Indianapolis
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Menerima pesertaFase 2
- Indiana University, Indianapolis
- Blue Coast Research Center, LLC, Indianapolis
- Franciscan Physician Network, Indiana Heart Physicians, Indianapolis
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Menerima pesertaFase 3
- Innovative Hematology, Inc., Indianapolis
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Menerima pesertaFase 3
- Innovative Hematology, Inc., Indianapolis
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
Menerima pesertaFase 3
- Indiana University, Indianapolis
Uji klinis Pendarahan di kota lain
- Boston, MA10 studi
- New York City, NY8 studi
- Houston, TX7 studi
- Atlanta, GA6 studi
- Cleveland, OH6 studi
- Chicago, IL6 studi
- Durham, NC5 studi
- Seattle, WA5 studi
- Philadelphia, PA5 studi
- St. Louis, MO5 studi
- Cedar Rapids, IA4 studi
- Washington, DC4 studi
Studi lain di Indianapolis
- Kanker Paru Non-Sel Kecil32 studi
- Kanker (semua jenis)24 studi
- Gagal Jantung23 studi
- Kanker Payudara20 studi
- Obesitas20 studi
- Kanker Metastatik19 studi
- Kanker Kolorektal18 studi
- Kanker Ovarium17 studi
- Kanker Paru16 studi
- Penyakit Kardiovaskular16 studi
- Diabetes Tipe 114 studi
- Kanker Endometrium14 studi
Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.